Keywords: intrabiotics, receives, milestone, payment, pharmacia, upjohn, pharmaceuticals
IntraBiotics Receives Milestone Payment From Pharmacia & Upjohn
Article | 03 December 1998
IntraBiotics Pharmaceuticals has received a $1 million milestonepayment from Pharmacia & Upjohn after sucessfully completing a Phase I study of Protegrin IB-367, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
